Skip to main content

Table 2 CV outcomes categories

From: Baseline diabetes as a way to predict CV outcomes in a lipid-modifying trial: a meta-analysis of 330,376 patients from 47 landmark studies

Total mortality

all-cause death

A

Composite

all CV events (including procedures)

B

 

MACE

C

 

CV death

D

Cardiac

total CHD/major coronary events

E

 

nonfatal CHD

F

 

cardiac death/fatal CHD

G

 

ACS/ACE

H

 

all MI

I

 

nonfatal MI

J

 

fatal MI

K

 

unstable/hospitalization-requiring AP

L

 

coronary revascularization (PCI or CABG)

M

 

life-threatening arrhytmias

N

 

resuscitation for cardiac arrest

O

 

sudden death

P

 

CHF

Q

Coronary imaging

angiographic CAD progression/change in coronary atheroma volume

R

Cerebrovascular

all major cerebrovascular events

S

 

all stroke/TIA

T

 

nonfatal stroke

U

 

fatal stroke

V

 

carotid revascularization

W

Other composite

non-CHD MACE

X

Other mortality

non-CHD CV death

Y

Peripheral

any PAD event (including revascularization and leg amputation)

Z

  1. ACE/ACS: acute coronary event/syndrome; AP angina pectoris; CABG: coronary artery bypass graft; CAD: coronary artery disease; CHD: coronary heart disease; CHF: congestive heart failure; CV: cardiovascular; MACE: major adverse cardiovascular event; MI myocardial infraction; PAD: peripheral arterial disease; PCI: percutaneous coronary intervention; TIA:transient is chemic attack (adapted from [91])